Noninvasive Cardioablation

Marwan M Refaat; Patrick Zakka; Bassem Youssef; Youssef H Zeidan; Fadi Geara; Amin Al-Ahmad

doi:10.1016/j.ccep.2019.05.008

Noninvasive Cardioablation

Card Electrophysiol Clin. 2019 Sep;11(3):481-485. doi: 10.1016/j.ccep.2019.05.008.

Authors

Marwan M Refaat¹, Patrick Zakka², Bassem Youssef³, Youssef H Zeidan³, Fadi Geara³, Amin Al-Ahmad⁴

Affiliations

¹ Cardiovascular Fellowship Program, Department of Internal Medicine, Cardiology Division, Cardiac Electrophysiology Section, American University of Beirut Faculty of Medicine and Medical Center (AUBMC), PO Box 11-0236, Riad El-Solh, Beirut 1107 2020, Lebanon. Electronic address: mr48@aub.edu.lb.
² Department of Internal Medicine, Emory University Hospital, 550 Peachtree Street Northeast, Atlanta, GA 30308, USA.
³ Department of Radiation Oncology, American University of Beirut Medical Center, PO Box 11-0236, Riad El-Solh, Beirut 1107 2020, Lebanon.
⁴ Texas Cardiac Arrhythmia Institute, St David's Medical Center, 919 East 32nd Street, Austin, TX 78705, USA.

PMID: 31400872
DOI: 10.1016/j.ccep.2019.05.008

Abstract

Stereotactic body radiotherapy uses the principle of 3-dimensional localization of a target to deliver a high dose of radiation to a precise location. The aim of this technique is to ablate tissue noninvasively. Because of its high precision and target conformity, it can deliver a high dose of radiation to a specific area in a tissue without significantly affecting nearby tissues. It is being actively studied and even used in therapy for atrial fibrillation and ventricular tachycardia.

Keywords: Ablation; Arrhythmia; Atrial fibrillation; Cardiac ablation; Noninvasive; Radioablation; Ventricular tachycardia.

Publication types

Review

MeSH terms

Arrhythmias, Cardiac* / physiopathology
Arrhythmias, Cardiac* / surgery
Humans
Radiosurgery*